Hogan SP - Search Results

1

Cytokines as targets for the inhibition of eosinophilic inflammation.

Hogan SP, Foster PS. Hogan SP, et al. Pharmacol Ther. 1997;74(3):259-83. doi: 10.1016/s0163-7258(97)00001-6. Pharmacol Ther. 1997. PMID: 9352584 Review.

2

Interleukin-5 and eosinophils as therapeutic targets for asthma.

Foster PS, Hogan SP, Yang M, Mattes J, Young IG, Matthaei KI, Kumar RK, Mahalingam S, Webb DC. Foster PS, et al. Among authors: hogan sp. Trends Mol Med. 2002 Apr;8(4):162-7. doi: 10.1016/s1471-4914(02)02302-x. Trends Mol Med. 2002. PMID: 11927273

3

Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.

Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, Hogan SP, Koskinen A, McKenzie AN, Dent LA, Rothenberg ME, Matthaei KI, Young IG, Foster PS. Mattes J, et al. Among authors: hogan sp. J Exp Med. 2002 Jun 3;195(11):1433-44. doi: 10.1084/jem.20020009. J Exp Med. 2002. PMID: 12045241 Free PMC article.

4

Experimental analysis of eosinophil-associated gastrointestinal diseases.

Hogan SP, Foster PS, Rothenberg ME. Hogan SP, et al. Curr Opin Allergy Clin Immunol. 2002 Jun;2(3):239-48. doi: 10.1097/00130832-200206000-00014. Curr Opin Allergy Clin Immunol. 2002. PMID: 12045421 Review.

5

Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity.

Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, Dent LA, Young IG, Matthaei KI, Rothenberg ME, Foster PS. Yang M, et al. Among authors: hogan sp. J Allergy Clin Immunol. 2003 Nov;112(5):935-43. doi: 10.1016/j.jaci.2003.08.010. J Allergy Clin Immunol. 2003. PMID: 14610483

6

ICAM-1-dependent pathways regulate colonic eosinophilic inflammation.

Forbes E, Hulett M, Ahrens R, Wagner N, Smart V, Matthaei KI, Brandt EB, Dent LA, Rothenberg ME, Tang M, Foster PS, Hogan SP. Forbes E, et al. Among authors: hogan sp. J Leukoc Biol. 2006 Aug;80(2):330-41. doi: 10.1189/jlb.1105643. Epub 2006 May 26. J Leukoc Biol. 2006. PMID: 16731772

7

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.

Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Foster PS, et al. Among authors: hogan sp. J Exp Med. 1996 Jan 1;183(1):195-201. doi: 10.1084/jem.183.1.195. J Exp Med. 1996. PMID: 8551223 Free PMC article.

8

Cellular and molecular mechanisms involved in the regulation of eosinophil trafficking in vivo.

Hogan SP, Foster PS. Hogan SP, et al. Med Res Rev. 1996 Sep;16(5):407-32. doi: 10.1002/(SICI)1098-1128(199609)16:5<407::AID-MED2>3.0.CO;2-Z. Med Res Rev. 1996. PMID: 8865149 Review.

9

Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins.

Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Hogan SP, et al. J Clin Invest. 1997 Mar 15;99(6):1329-39. doi: 10.1172/JCI119292. J Clin Invest. 1997. PMID: 9077543 Free PMC article.

10

Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice.

Hogan SP, Koskinen A, Foster PS. Hogan SP, et al. Immunol Cell Biol. 1997 Jun;75(3):284-8. doi: 10.1038/icb.1997.43. Immunol Cell Biol. 1997. PMID: 9243294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters